Literature DB >> 8351014

Prevalence of myotonic dystrophy in Guipúzcoa (Basque Country, Spain).

A López de Munain1, A Blanco, J I Emparanza, J J Poza, J F Martí Massó, A Cobo, L Martorell, M Baiget, J M Martínez Lage.   

Abstract

Prevalence figures for inherited neuromuscular disorders are important both for health care planning purposes and for evaluating the need for DNA diagnostic services for eugenic approaches. We screened for the prevalence of myotonic dystrophy (MyD) through extensive inquiry of neurologic and primary health services of Guipúzcoa (Basque Country, northern Spain) between 1989 and 1991. Typical adult-onset and neonatal cases and relatives at risk; suffering from a partial syndrome, were included. In the latter, molecular typing was performed with DNA probes close to the MyD gene to demonstrate the MyD gene carrier status. The high prevalence detected (26.5 cases per 100,000 population) could be explained by methodological factors, but intrinsic factors, such as a possible founder genetic effect or the quick growth of the Guipúzcoa population since the last century may contribute to one of the highest MyD prevalence in the world. In the future, the methodological basis for epidemiologic surveys of MyD must combine molecular technology with more-extensive family inquiries.

Entities:  

Mesh:

Year:  1993        PMID: 8351014     DOI: 10.1212/wnl.43.8.1573

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Frequency of myotonic dystrophy gene carriers in cataract patients.

Authors:  A M Cobo; J J Poza; A Blanco; A López de Munain; A Saénz; M Azpitarte; J Marchessi; J F Martí Massó
Journal:  J Med Genet       Date:  1996-03       Impact factor: 6.318

2.  The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care.

Authors:  Marie De Antonio; Céline Dogan; Ferroudja Daidj; Bruno Eymard; Jack Puymirat; Jean Mathieu; Cynthia Gagnon; Sandrine Katsahian; Dalil Hamroun; Guillaume Bassez
Journal:  Orphanet J Rare Dis       Date:  2019-06-03       Impact factor: 4.123

3.  Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study.

Authors:  Garazi Labayru; Jone Aliri; Miren Zulaica; Adolfo López de Munain; Andone Sistiaga
Journal:  J Neuropsychol       Date:  2019-08-13       Impact factor: 2.864

4.  White matter integrity changes and neurocognitive functioning in adult-late onset DM1: a follow-up DTI study.

Authors:  Garazi Labayru; Borja Camino; Antonio Jimenez-Marin; Joana Garmendia; Jorge Villanua; Miren Zulaica; Jesus M Cortes; Adolfo López de Munain; Andone Sistiaga
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

Review 5.  Muscle wasting in myotonic dystrophies: a model of premature aging.

Authors:  Alba Judith Mateos-Aierdi; Maria Goicoechea; Ana Aiastui; Roberto Fernández-Torrón; Mikel Garcia-Puga; Ander Matheu; Adolfo López de Munain
Journal:  Front Aging Neurosci       Date:  2015-07-09       Impact factor: 5.750

Review 6.  Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.

Authors:  Laurène M André; C Rosanne M Ausems; Derick G Wansink; Bé Wieringa
Journal:  Front Neurol       Date:  2018-05-28       Impact factor: 4.003

7.  Social cognition in myotonic dystrophy type 1: Specific or secondary impairment?

Authors:  Garazi Labayru; Irati Arenzana; Jone Aliri; Miren Zulaica; Adolfo López de Munain; Andone Sistiaga A
Journal:  PLoS One       Date:  2018-09-24       Impact factor: 3.240

8.  Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1.

Authors:  Garazi Labayru; Ibai Diez; Jorge Sepulcre; Esther Fernández; Miren Zulaica; Jesús M Cortés; Adolfo López de Munain; Andone Sistiaga
Journal:  Neuroimage Clin       Date:  2019-11-06       Impact factor: 4.881

Review 9.  Targeting Myotonic Dystrophy Type 1 with Metformin.

Authors:  Mikel García-Puga; Ander Saenz-Antoñanzas; Ander Matheu; Adolfo López de Munain
Journal:  Int J Mol Sci       Date:  2022-03-07       Impact factor: 5.923

10.  Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration.

Authors:  Antonio Jimenez-Marin; Ibai Diez; Garazi Labayru; Andone Sistiaga; Maria C Caballero; Pol Andres-Benito; Jorge Sepulcre; Isidro Ferrer; Adolfo Lopez de Munain; Jesus M Cortes
Journal:  Neuropathol Appl Neurobiol       Date:  2021-05-17       Impact factor: 6.250

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.